期刊文献+

普罗布考对甲基胍诱导纤维化相关因子在HK-2细胞表达的影响 被引量:1

Effect of probucol on the expression of fibrosis correlation factor in HK-2 cells caused by methylguanidine
下载PDF
导出
摘要 目的研究降脂药普罗布考对小分子尿毒素甲基胍诱导纤维化相关因子在人肾小管上皮细胞表达的影响。方法 HK-2细胞分3组培养,A组(正常对照,不加干预因素);B组培养基中加入0.5mmol.L-1甲基胍;C组培养基中加入0.5mmol.L-1甲基胍和20μmol.L-1普罗布考。各组细胞培养48h后用免疫细胞化学、RT-PCR检测TGF-β1、CTGF和FN,并用流式细胞仪对以上因子作定量检测,以观察其在HK-2细胞中的表达。结果在甲基胍刺激后,细胞免疫化学染色,HK-2细胞质中着色,显示TGF-β1、CTGF和FN均有表达。正常对照组HK-2细胞质中无着色。测定结果显示甲基胍组TGF-β1、CTGF和FN显著高于正常对照组(P<0.01),加入普罗布考后,表达显著下降(P<0.01)。结论甲基胍能促进纤维化相关因子在肾小管上皮细胞中表达;普罗布考能抑制甲基胍诱导纤维化相关因子在肾小管上皮细胞的表达。 Objective To investigate the effect of probucol on mRNA expression of the fibrotic correlation factors on human renal tubular epithelial cell line (HK-2) with the intervention of methylguanidine.Methods HK-2 cells were treated with nothing in group A,0.5 mmol·L-1 methylguanidine in group B,and 0.5 mmol·L-1 methylguanidine and 20 μmol·L-1 probucol in group C.The protein and mRNA expression of TGF-β1,CTGF and FN were examined by immunocytochemistry,flow cytometry and RT-PCR.Results The protein and mRNA expression of TGF-β1,CTGF and FN in HK-2 cells were significantly increased when HK-2 cells were cultivated with methylguanidine(P0.01),but when probucol was added they decreasd (P0.01).Conclusion Methylguanidine can promote the expression of fibrosis correlation factors in renal tubular epithelial cells.Probucol can inhibit the expression of fibrosis correlation factors in renal tubular epithelial cells caused by methylguanidine.
出处 《中南药学》 CAS 2010年第5期336-340,共5页 Central South Pharmacy
关键词 普罗布考 甲基胍 肾小管上皮细胞 纤维化 probucol methylguanidine renal tubular epithelial cell fibrosis
  • 相关文献

参考文献14

二级参考文献87

  • 1陈荣权,陈香美,崔世维,蔡广研,师锁柱,谢院生,吕杨,彭丽霞.基质金属蛋白酶/组织金属蛋白酶抑制物表达失衡在衰老大鼠肾小管间质损害中的意义[J].中华医学杂志,2004,84(11):937-942. 被引量:28
  • 2武强,刘郑荣.慢性肾功能不全病人中的氧化应激现象观察[J].实用医学杂志,2004,20(10):1160-1161. 被引量:8
  • 3朱辟疆.细胞外基质与肾小球硬化[J].中国中西医结合肾病杂志,2000,1(2):123-125. 被引量:40
  • 4Parfrey P S, Foley R N, Harnett J D, et al. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int, 1996, 49:1428-1434. 被引量:1
  • 5Himmelfarb J, Stenvinkel P, Ikizler TA, et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int, 2002, 62: 1524-1538. 被引量:1
  • 6Locatelli F, Canaud B, Eckardt K U, et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant, 2003, 18: 1272-1280. 被引量:1
  • 7National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002, 39 (2 Suppl 1): S1-S266. 被引量:1
  • 8Witko-Sarsat V, Friedlander M, Nguyen Khoa T, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol, 1998, 161: 2524-2532. 被引量:1
  • 9Vaziri N D, Oveisi F, Ding Y. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int, 1998, 53:1748-1754. 被引量:1
  • 10Tepel M, Echelmeyer M, Orie NN, et al. Increased intracellular reactive oxygen species in patients with end-stage renal failure: effect of hemodialysis. Kidney Int, 2000, 58: 867-872. 被引量:1

共引文献88

同被引文献21

  • 1Watanabe H. Molecular mechanisms for uremic toxin- in- duced oxidative tissue damage via a cardiovascular-re- nal connection[J]. Yakugaku Zasshi, 2013,133(8):889-895. 被引量:1
  • 2Rossi M, Campbell KL, Johnson DW, et al. Uremic toxin de- velopment in living kidney donors: a longitudinal study [J]. Transplantation, 2014,97(5):548-554. 被引量:1
  • 3Moradi H, Sica DA, Kalantar- Zadeh K. Cardiovascular Burden Associated with Uremic Toxins in Patients with Chronic Kidney Disease[J].Nephrology, 2013,38:136-148. 被引量:1
  • 4Ramezani A, Raj DS. The gut mierobiome, kidney disease, and targeted interventions[J]. J Am Soc Nephrol, 2014,25 (4):657-670. 被引量:1
  • 5Vitetta L, Manuel R, Zhou JY, et al. The overarehing in- fluence of the gut mierobiome on end-organ function: the role of live probiotie cultures[J]. Pharmaceuti- cals (Basel),2014,7(9):954-989. 被引量:1
  • 6Radford-MG Jr, Donadio-JV Jr, Bergstralh EJ, et al. Pre- dicting renal outcome in IgA nephropathy[J]. J Am Soc Nephrol, 1997,8(2):199-207. 被引量:1
  • 7Lin SL, Chen RH, Chen YM, et al. Pentoxifylline attenu- ates tubulointerstitial fibrosis by blocking Smad3/4- activated transcription and profibrogenic effects of connective tissue growth factor[J]. J Am Soc Nephrol, 2005,16(9):2702-2713,. 被引量:1
  • 8Vaziri ND, Wong J, Pahl M, et al. Chronic kidney disease alters intestinal microbial flora[J]. Kidney Int, 2013, 83(2):308-315. 被引量:1
  • 9Miranda-Alatriste PV, Urbina-Arronte R, Gomez-Espinosa CO, et al. Effect of probiotics on human blood urea levels in patients with chronic renal failure[J].Nutr Hosp, 2014, 19(3):582-590. 被引量:1
  • 10Sung CC, Hsu YC, Chen CC, et al. Oxidative Stress and Nu- cleic Acid Oxidation in Patients with Chronic Kidney Disease[J].Oxidative Medicine and Cellular Longevity, 2013:1-15. 被引量:1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部